Yeah. I reckon Pharmorage might follow a similar route to Nyrada, and take their new pipeline drugs to an IPO. Personally I like this approach, with NOX holding a big chunk.
But for Veyonda and COVID, should it prove viable? Whatever the quickest route, which I guess is partner and licensing to whoever can run with it.
- Forums
- ASX - By Stock
- NOX
- Ann: NOXCOVID Program to Expand After Positive Phase 1 Results
Ann: NOXCOVID Program to Expand After Positive Phase 1 Results, page-36
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.3¢ |
Change
0.005(7.35%) |
Mkt cap ! $21.33M |
Open | High | Low | Value | Volume |
7.0¢ | 7.3¢ | 7.0¢ | $2.227K | 30.76K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 43261 | 6.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.4¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 43261 | 0.069 |
1 | 9132 | 0.068 |
1 | 15000 | 0.065 |
1 | 79000 | 0.063 |
1 | 100000 | 0.062 |
Price($) | Vol. | No. |
---|---|---|
0.076 | 4999 | 1 |
0.079 | 12000 | 1 |
0.080 | 100000 | 1 |
0.081 | 22345 | 2 |
0.083 | 28000 | 1 |
Last trade - 15.59pm 07/08/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |